吲哚美辛栓质量分析
Quality analysis for the domestic dosage form of indometacin suppositories
分类号:
出版年·卷·期(页码):2012,32 (7):0-0
DOI:
10.16155/j.0254-1793.2017.01.01
-----摘要:-------------------------------------------------------------------------------------------
目的: 评价国产吲哚美辛栓的质量现状和问题。 方法: 按照2010年度国家评价性抽验计划,采用法定检验方法结合探索性研究进行样品检验。 结果: 本文采用英国药典32版和2005年版中国药典方法,通过专属性实验和各厂家样品杂质含量结果的比较,证实2005年中国药典方法更为简便,而2个主要杂质经质谱分析,证明为工艺杂质,来源于原料。采用美国药典32版溶出度方法检查样品的溶出情况,发现国内产品采用脂溶性基质,国外产品采用水溶性基质,两者溶出情况不一致。 结论: 目前吲哚美辛栓的产品质量能符合现行标准的要求;探索性研究提示可以以提高吲哚美辛原料质量的方式,提高制剂质量。
-----英文摘要:---------------------------------------------------------------------------------------
Objective: To evaluate the quality status of domestic dosage form of indometacin suppositories. Methods: According to the general requirements of national assessment programs in 2010 use statutory testing methods and combine with the exploratory research to examine sample,evaluate the quality status of domestic dosage form of indometacin suppositories. Results: In this paper, we proved that the HPLC method of ChP is simple, by comparing the investigation of specificity and results of related substance between BP and ChP. We confirm that the two major impurities come from synthetic process of material. We find that domestic dosage form and import dosage form are different through the dissolution test of USA, because the domestic dosage form is fat-solubility suppository and the import dosage form is water-solubility suppository. Conclusions: At present the products quality of indometacin suppositories can meet the current standards. The exploratory research suggests that we can control the impurities of material to increase the quality of dosage.
-----参考文献:---------------------------------------------------------------------------------------
1 ChP(中国药典).2005.Vol Ⅱ(二部):256
2 USP.32.2009.Volume 2:2635
3 BP.2009.Volume Ⅲ:2676
4 JP(日本药局方).XV.2006.757
5 ZHANG Xiao-lu(张晓璐),DAI Xi-di(戴夕娣),DING Jian(丁建).RP-HPLC determination of indometacin in compound indometacin cream(高效液相色谱法测定复方吲哚美辛乳膏中吲哚美辛的含量).Chin J Pharm Anal(药物分析杂志),2007,27(8):1269
6 MAO Li(冒莉),ZHENG Qi-tai(郑启泰),LV Yang(吕扬).Progress on the study of solid drug polymorphism(固体药物多晶型的研究进展).Nat Prod Res Dev(天然产物研究与开发),2005,17(3):371
7 Pharmacopeia annotation(《药典注释》),1990, Vol II(二部):267
8 LIU Yi(刘毅),YUE Zhi-hua(岳志华),NING Bao-ming(宁保明),et al. Study on the polymorphism of mexiletine hydrochloride(盐酸美西律多晶型研究).Chin J Pharm Anal(药物分析杂志),2008,28(9):1503
9 WANG Wei(王维),WANG Jin(王瑾).Quality evaluation of indometacin and its Enteric-coated tablets(吲哚美辛原料及肠溶片剂质量再评价).Chin J Pharm Anal(药物分析杂志),1997,17(4):27110 XI Nian-zhu(奚念朱).Pharmaceutics(药剂学).3rd (第三版).Beijing(北京):The Peoples Medical Publishing House(人民卫生出版社),1998.401
11 HONG Xiu-ping(洪秀萍).An research of allergic asthma evoked by indometacin suppositories(消炎痛栓诱发过敏性哮喘1例分析).China J Misdiagn(中国误诊学杂志),2009,9(3):723
12 WU Ai-dong(邬爱东).Nursing care and inspiration of five elderly patient cases with shock induced by indometacin suppositories(消炎痛栓退热致5例老年患者休克的护理与启示).J Nurs(China)(护理学报),2009,16(3B):56
13 WU Yan(吴燕),ZHANG Li-jun(张利军).Two hypertension cases evoked by indometacin suppositories(吲哚美辛栓引诱发高血压二例).China New Technol Prod(中国新技术新产品),2008,(9):16
欢迎阅读《药物分析杂志》!您是该文第 1702位读者!